chr15-45402642-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 4P and 1B. PS1_ModeratePM2BP4
The ENST00000305560.11(AFG2B):c.213T>G(p.Phe71Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000583 in 1,579,296 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin UniProt.
Frequency
Consequence
ENST00000305560.11 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPATA5L1 | NM_024063.3 | c.213T>G | p.Phe71Leu | missense_variant | 1/8 | ENST00000305560.11 | NP_076968.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AFG2B | ENST00000305560.11 | c.213T>G | p.Phe71Leu | missense_variant | 1/8 | 1 | NM_024063.3 | ENSP00000305494 | P1 | |
AFG2B | ENST00000559860.2 | n.273T>G | non_coding_transcript_exon_variant | 1/5 | 2 | |||||
AFG2B | ENST00000531970.5 | c.213T>G | p.Phe71Leu | missense_variant, NMD_transcript_variant | 1/8 | 2 | ENSP00000436823 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152140Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000543 AC: 10AN: 184116Hom.: 0 AF XY: 0.0000489 AC XY: 5AN XY: 102252
GnomAD4 exome AF: 0.0000582 AC: 83AN: 1427040Hom.: 1 Cov.: 34 AF XY: 0.0000678 AC XY: 48AN XY: 708066
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152256Hom.: 0 Cov.: 33 AF XY: 0.0000806 AC XY: 6AN XY: 74446
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2023 | AFG2B: PM2, PM3:Supporting, PP3 - |
Neurodevelopmental disorder with hearing loss and spasticity Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen | May 12, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at